Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors in Treatment of Glioblastoma
Glioma is the most common primary intracranial tumor, and most patients present as glioblastoma, with high morbidity and mortality. The prognosis of patients with glioblastoma remains poor after surgical resection combined with standardized treatment of radiotherapy and chemotherapy. In recent years...
| Published in: | Zhongliu Fangzhi Yanjiu |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | Chinese |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2022-05-01
|
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.1069 |
